Marina F. Rzyankina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marina F. Rzyankina has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Ksenia E. Potapova
Far Eastern State Medical University of the Ministry of Health of the Russian Federation
4 shared publications - A. A. Kulik
КГБУЗ «Родильный дом им. Зинаиды и Федора Венцовых» Министерства здравоохранения Хабаровского края
1 shared publication - Aleksander V. Gorelov
Sechenov First Moscow State Medical University (Sechenov University)
1 shared publication - Aleksandr M. Shabalov
Kirov Military Medical Academy
1 shared publication - Alexandra K. Starkova1 shared publication
- Anna A. Arova
Volgograd State Medical University
1 shared publication
Latest Publications
- Open Access
- 21 June 2026
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 2,p. 9-14
Criteria for early diagnosis of neonatal neurological abnormalities by mode of delivery
The article presents an analysis of the impact of cesarean section (CS) on the health of newborns, driven by the high (28.5%) and continuously growing rate of operative delivery in the Russian Federation. The aim of the work was to develop an algorithm for the early detection of hypoxic, metabolic, and neurological disorders in children. The study included a retrospective analysis of 6629 births and a prospective observation of 104 full-term newborns (after vaginal delivery, planned, and emergency CS). It was established that CS, especially emergency CS, is associated with a higher frequency of neurological abnormalities (62-67% versus 18% in vaginal delivery), metabolic stress (lactate level 4.4 mmol/L), and problems with breastfeeding. Independent predictors of neonatal disorders were identified. Based on the obtained data, a two-stage monitoring algorithm (in the maternity hospital and outpatient setting) was developed for the timely diagnosis and prevention of pathologies in children born by CS.
- 21 June 2026
- Published by Yakutsk Scientific Center for Complex Medical Problems in Yakut Medical Journal
- No. 2,p. 9-14
Open AccessCriteria for early diagnosis of neonatal neurological abnormalities by mode of delivery
The article presents an analysis of the impact of cesarean section (CS) on the health of newborns, driven by the high (28.5%) and continuously growing rate of operative delivery in the Russian Federation. The aim of the work was to develop an algorithm for the early detection of hypoxic, metabolic, and neurological disorders in children. The study included a retrospective analysis of 6629 births and a prospective observation of 104 full-term newborns (after vaginal delivery, planned, and emergency CS). It was established that CS, especially emergency CS, is associated with a higher frequency of neurological abnormalities (62-67% versus 18% in vaginal delivery), metabolic stress (lactate level 4.4 mmol/L), and problems with breastfeeding. Independent predictors of neonatal disorders were identified. Based on the obtained data, a two-stage monitoring algorithm (in the maternity hospital and outpatient setting) was developed for the timely diagnosis and prevention of pathologies in children born by CS.
- Open Access
- 14 February 2026
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 97 (12) , 1037-1043
Probiotics’ position in clinical practice: focus on the combination of Lactobacillus acidophilus (LA-5) and Bifidobacterium animalis subsp. lactis (BB-12). A review
Probiotics are currently widely used in clinical practice to prevent and treat a wide range of diseases. The purpose of our review is to highlight what we consider to be the most significant clinical studies on the use of probiotics for preventing antibiotic-associated diarrhea, clostridial diarrhea and pseudomembranous colitis. The article also presents the results of studies confirming the efficacy of probiotics in Helicobacter pylori eradication therapy. The review focuses on Linex® Forte, medicinal product containing the combination of Lactobacillus acidophilus (LA-5) and Bifidobacterium animalis subsp. lactis (BB-12).
- 14 February 2026
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 97 (12) , 1037-1043
Open AccessProbiotics’ position in clinical practice: focus on the combination of Lactobacillus acidophilus (LA-5) and Bifidobacterium animalis subsp. lactis (BB-12). A review
Probiotics are currently widely used in clinical practice to prevent and treat a wide range of diseases. The purpose of our review is to highlight what we consider to be the most significant clinical studies on the use of probiotics for preventing antibiotic-associated diarrhea, clostridial diarrhea and pseudomembranous colitis. The article also presents the results of studies confirming the efficacy of probiotics in Helicobacter pylori eradication therapy. The review focuses on Linex® Forte, medicinal product containing the combination of Lactobacillus acidophilus (LA-5) and Bifidobacterium animalis subsp. lactis (BB-12).